Gregory Hapgood

12PUBLICATIONS

85CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAnimal immunologyLiquid biopsies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jun 11, 2026

High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Sep 24, 2025

Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.

Franck Morschhauser, Gilles Salles, Laurie H Sehn

|Feb 13, 2025

An Economic Evaluation of the TROG 99.03 Trial: Systemic Therapy After Radiotherapy in Early-Stage Follicular Lymphoma.

Daniel Erku, Joshua W D Tobin, John F Seymour

|Jan 18, 2025

Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature review.

Luke Wang, Eliza Chung, Cameron Wellard

|Oct 13, 2024

The value of semiquantitative PET features and end-of-therapy PET in grade 3B follicular lymphoma.

Allison Barraclough, Sze Ting Lee, Diego Villa

|Aug 05, 2024

Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.

Joshua W D Tobin, Greg Hapgood, Anna Johnston

Pageof 2

Frequent Collaborators

Eliza Hawkes

Judith Trotman

Matthew Ku

Michael Dickinson

Pietro R Di Ciaccio

Nada Hamad

Chan Y Cheah

Joshua W D Tobin

Matthew Greenwood

Jeff Szer

Frequent Collaborators

Eliza Hawkes

Judith Trotman

Matthew Ku

Michael Dickinson